Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Salivary Gland Neoplasms × cabozantinib × Clear all

Sponsor

Conditions

Prostatic Neoplasms 13 Carcinoma, Renal Cell 12 Neoplasm Metastasis 7 Neoplasms 6 Carcinoma, Hepatocellular 5 Thyroid Neoplasms 4 Melanoma 4 Carcinoma, Non-Small-Cell Lung 4 Carcinoma, Medullary 4 Breast Neoplasms 4 Brain Neoplasms 4 Pancreatic Neoplasms 3 Neuroendocrine Tumors 3 Thyroid Cancer, Papillary 2 Small Cell Lung Carcinoma 2 Recurrence 2 Pain 2 Multiple Myeloma 2 Lung Neoplasms 2 Kidney Neoplasms 2 Glioma 2 Glioblastoma 2 Carcinoma, Transitional Cell 2 Carcinoma 2 Astrocytoma 2 Adenoma, Islet Cell 2 Adenocarcinoma, Follicular 2 Adenocarcinoma 2 Uveal Melanoma 1 Urinary Bladder Neoplasms 1

Interventions

Cetuximab 3 Vorinostat 2 Radiosurgery 2 Nivolumab 2 Ipilimumab 2 Dasatinib 2 Cisplatin 2 Bevacizumab 2 temsirolimus 1 pembrolizumab 1 ispinesib 1 eribulin 1 dehydroftorafur 1 apalutamide 1 alectinib 1 Sorafenib 1 Sirolimus 1 Platinum 1 Pilocarpine 1 Oral Hygiene 1 N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine 1 Moxibustion 1 Magnetic Resonance Spectroscopy 1 MK 2206 1 Lapatinib 1 Irinotecan 1 Immunoglobulin G 1 Gonadotropin-Releasing Hormone 1 Gemcitabine 1 Gefitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡